AMAC was recently asked by the House Health Subcommittee (part of the Energy and Commerce Committee) to provide our support to retain the current structure of Medicare Part D, which is the prescription drug aspect of the Medicare program. The Centers for Medicare and Medicaid Services are currently proposing changes that may threaten access and choice of medications for physicians and the seniors that they treat. AMAC recognizes that Medicare Part D, in its current constitution, has been overwhelmingly successful in driving down medication costs for seniors while providing access to an extensive selection of drugs with which physicians may choose to treat their patients. Medicare Part D is a private-public partnership that not only works, but has positively impacted the lives of the seniors it was created to serve.
February 25th, 2014
The Honorable Joe Pitts The Honorable Frank Pallone, Jr.
16th District, Pennsylvania 6th District, New Jersey
420 Cannon House Office Building 237 Cannon House Office Building
Washington, DC 20515 Washington, DC 20515
Dear Chairman Pitts and Ranking Member Pallone,
On behalf of the 1.1 million members of the Association of Mature American Citizens (AMAC), I am writing to express our deep concern regarding newly proposed regulations for the Medicare Part D prescription drug program and how they may negatively impact the health care coverage of mature Americans and seniors.
AMAC is in favor of leaving the Medicare Part D market-based, public-private partnership between drug manufacturers and health plan sponsors in its current structure. The majority of medication costs have already come out of the Part D program due to the generic status of the many maintenance drugs that are commonly prescribed. Generic drug usage dominates throughout the program and provides many choices for both physicians and patients. If anything, interference by the Centers for Medicare and Medicaid Services in the Part D program – particularly with protected class medications – could limit access to drugs and sharply reduce choice.
As a champion of free market solutions, AMAC remains concerned that these new regulations will unnecessarily expand the government’s role in the Medicare Part D program, ultimately leading to unnecessary burdens and costs to providers and consumers. AMAC is also concerned that the proposed regulations appear to conflict with the intent of Part D as it was originally written, and deliberately circumvent Congressional processes.
AMAC strongly opposes attempts by the Administration to exert more control over valued programs like Medicare Part D that already work efficiently and effectively and enjoy significant popularity among older Americans.
As the fastest-growing seniors’ advocacy organization in the country, AMAC remains committed to ensuring that mature Americans are able to maintain access to the cost-effective Medicare Part D benefits they prefer. Thank you for your concern and attention to this critical matter.
President and Founder of AMAC